Viking Therapeutics Inc (VKTX)

Massachusetts Financial Services Co. MA Invests $12.34 Million in Viking Therapeutics, Inc. (NASDAQ:VKTX) - MarketBeat

MarketBeat

3 Monster Stocks in the Making You Can Buy Right Now

The Motley Fool

Viking Therapeutics (NASDAQ:VKTX) Upgraded at Raymond James - Defense World

Defense World

Viking Therapeutics (NASDAQ:VKTX) Stock Rating Upgraded by StockNews.com - MarketBeat

MarketBeat

Viking Therapeutics (NASDAQ:VKTX) Upgraded to Sell at StockNews.com - Defense World

Defense World

Pharma Stocks Outlook: Where Are 2024's Top Performers Headed Next? - InvestorPlace

InvestorPlace

Pharma Stocks Outlook: Where Are 2024's Top Performers Headed Next? - InvestorPlace

InvestorPlace

Emerging Leaders: Roche, Viking Therapeutics In The Obesity Treatment Race (OTCMKTS:RHHBY) - Seeking Alpha

Seeking Alpha

Smart Money Is Betting Big In VKTX Options - Viking Therapeutics (NASDAQ:VKTX) - Benzinga

Benzinga

4 Stocks That Could Break Novo Nordisk, Lilly's Obesity Duopoly

Zacks Investment Research

Is Viking Therapeutics Stock a Buy?

The Motley Fool

MSN - MSN

MSN

Biotech Stock Roundup: PRAX, VKTX Up on Study Results & MRNA, REGN Give Updates - MSN

MSN

Viking Therapeutics posts positive results for oral weight-loss drug. Analysts remain unanimous the stock's a buy. - MSN

MSN

Viking Therapeutics (NASDAQ:VKTX) Upgraded to Strong-Buy at Raymond James - MarketBeat

MarketBeat

Viking Therapeutics (NASDAQ:VKTX) Shares Gap Down to $78.01 - MarketBeat

MarketBeat

Truist maintains $120 target on Viking Therapeutics stock By Investing.com - Investing.com

Investing.com

Viking stock falls after Roche's obesity data (NASDAQ:VKTX) - Seeking Alpha

Seeking Alpha

Viking stock falls after Roche's obesity data (NASDAQ:VKTX) - Seeking Alpha

Seeking Alpha

Viking Therapeutics' (VKTX) "Buy" Rating Reaffirmed at Truist Financial - MarketBeat

MarketBeat

Viking stock falls after Roche obesity data (NASDAQ:VKTX) - Seeking Alpha

Seeking Alpha

Should You Hold Viking Therapeutics (VKTX) in Your Portfolio? - MSN

MSN

Here's How Much $1000 Invested In Viking Therapeutics 5 Years Ago Would Be Worth Today By Benzinga - Investing.com UK

Investing.com UK

Should You Hold Viking Therapeutics (VKTX) in Your Portfolio? - Yahoo Finance

Yahoo Finance

Should You Hold Viking Therapeutics (VKTX) in Your Portfolio? - Zacks Investment Research

Zacks Investment Research

Eli Lilly (LLY) Settles With Spa Selling Mounjaro, Zepbound Copies

Zacks Investment Research

How Is The Market Feeling About Viking Therapeutics? - Viking Therapeutics (NASDAQ:VKTX) - Benzinga

Benzinga

Is Viking Therapeutics the Best Biotech Stock for You? - MSN

MSN

Viking Therapeutics (NASDAQ:VKTX) Shares Down 3.4% - MarketBeat

MarketBeat

How Viking Therapeutics Stock Could 30x - Yahoo Finance

Yahoo Finance

Is Viking Therapeutics the Best Biotech Stock for You? - AOL

AOL

What Makes Viking Therapeutics An Attractive Takeover Target Or Big Pharma Partner (VKTX) - Seeking Alpha

Seeking Alpha

Russell Investments Group Ltd. Purchases Shares of 256,633 Viking Therapeutics, Inc. (NASDAQ:VKTX) - MarketBeat

MarketBeat

How Much Are Viking Therapeutics, Inc. (NASDAQ:VKTX) Insiders Spending On Buying Shares? - Yahoo Lifestyle Australia

Yahoo Lifestyle Australia

Viking Therapeutics: The Metabolic Masterpiece Primed To Be Acquired (NASDAQ:VKTX) - Seeking Alpha

Seeking Alpha

Viking Therapeutics: The Metabolic Masterpiece Primed To Be Acquired (NASDAQ:VKTX) - Seeking Alpha

Seeking Alpha

Viking Therapeutics's Options Frenzy: What You Need to Know - Viking Therapeutics (NASDAQ:VKTX) - Benzinga

Benzinga

Ligand (LGND) Beats Q1 Earnings, Misses Sales Estimates

Zacks Investment Research

We Think Viking Therapeutics (NASDAQ:VKTX) Can Afford To Drive Business Growth - Yahoo News UK

Yahoo News UK

Viking Therapeutics's Options Frenzy: What You Need to Know - Viking Therapeutics (NASDAQ:VKTX) - Benzinga

Benzinga

Here’s Why Viking Therapeutics Rose Over 50% on Obesity Drug Data - The Globe and Mail

The Globe and Mail

Analysts Set Viking Therapeutics, Inc. (NASDAQ:VKTX) Target Price at $112.25 - Defense World

Defense World

Eli Lilly Raised Its Outlook. Is the Stock a Buy Now?

The Motley Fool

Viking Therapeutics CFO sells over $4.9 million in company stock - Investing.com

Investing.com

Viking Therapeutics Delivers Smaller-Than-Expected Q1 Loss - The Motley Fool

The Motley Fool

Is Viking Therapeutics Incredibly Undervalued?

The Motley Fool

Can This High-Flying Stock 10x in 10 Years?

The Motley Fool

1 Little-Known Vanguard Index Fund to Buy Before It Soars 50%, According to a Wall Street Analyst

The Motley Fool

Is Viking Therapeutics Incredibly Undervalued? - Nasdaq

Nasdaq

We Think Viking Therapeutics (NASDAQ:VKTX) Can Easily Afford To Drive Business Growth - Simply Wall St

Simply Wall St